Start your 7-day free trial
Full access to AI-powered biotech signal intelligence. Cancel anytime before day 7 and pay nothing.
- ✓ Public stock pages (700+ tickers)
- ✓ PDUFA calendar with PoA scores
- ✓ Historical FDA outcomes
- ✓ Big movers & earnings calendar
- ✕ Personal watchlist
- ✕ AI briefings & alerts
- ✕ Scanner & trade setups
- ★ Unlimited watchlist tickers
- ★ AI daily briefings
- ★ BioRadar Scanner (500 stocks)
- ★ AI Trade Setups with entry/stop/target
- ★ Email + PDUFA alerts
- ★ Cash runway & dilution analysis
- ★ Squeeze scoring & analyst targets
- ★ Probability of Approval on every catalyst
Questions traders ask before the trial
FDA calendars are free. Why pay for BioRadar?
Ours is free too. The PDUFA calendar, approval probabilities, historical FDA outcomes and 700+ stock pages with their SEC filings in plain English need no account. A calendar shows the decision date. It doesn't show the offering, the warrant overhang or the 8-K that lands in between.
Premium watches the stocks you hold. Your dashboard shows each one's cash runway and every tool the company can use to add shares: shelf capacity, ATM programs, warrants and convertible notes. When something material happens, you get an email. See how BioRadar compares with other catalyst tools.
What do I get in the first ten minutes?
Add the stocks you own or follow. For each one, the dashboard shows the next catalysts with their source, cash runway, financing tools and share growth, insider trades, short interest and a three-bullet AI briefing. Email alerts are on for every ticker from the moment you add it.
I can't watch the market all day. What will you email me?
Only events that change the picture for a stock on your watchlist. For example: a PDUFA date less than a week away, an FDA decision, a new financing, an 8-K with trial results, an FDA letter, a deal or a Nasdaq notice, a milestone the company has pushed back, or a bankruptcy, sale or deregistration.
There is no daily mailing: if nothing happens, you hear nothing. Any alert type can be switched off per ticker on your dashboard.
How do I know the AI isn't making things up?
You can see what you're reading. Dashboard panels are labeled Reported (SEC, FDA, ClinicalTrials.gov, FINRA and exchange data), Estimate (calculated by BioRadar from reported data) or AI (written or rated by a model).
SEC filing summaries are written from the filing text alone. If a summary mentions a number or a name that isn't in the filing, it is dropped instead of shown, and every summary links to the original on SEC.gov. Approval probabilities start from base rates checked against verified FDA outcomes, then adjust for the application type, therapy area, cash runway and any problem the FDA has raised that the company has disclosed.
Who is BioRadar not for?
Day traders who need Level 2 and tick-by-tick quotes: keep your broker's platform for that. BioRadar is built for people who hold biotech stocks through catalysts, for days or months, and want filings, cash and dilution in one place.
How does the free trial work?
You add a card to start, but you're not charged during the 7-day trial. Cancel anytime before it ends and you pay nothing. If you keep it, billing starts automatically at $15/month.
Can I cancel anytime?
Yes. Click "Manage Subscription" above to cancel, pause, or change your plan. No lock-in.
What payment methods are accepted?
All major credit cards via Stripe. Your payment info is never stored on our servers.
Is this financial advice?
No. BioRadar is a data aggregation and signal detection tool. All data is for informational purposes only. Always do your own research.